Sleep and Immune Mechanisms in Rheumatoid Arthritis: Remicade Substudy.
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 27 Jun 2012 Actual patient number is 36 according to ClinicalTrials.gov.
- 27 Jun 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 27 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.